FindTrial
Sign In

The effect of plasma renin activity on the selection of antihypertensive drugs

The effect of plasma renin activity on the selection of antihypertensive drugs

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17012332
Enrollment
Unknown
Registered
2017-08-10
Start date
2017-09-01
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Resistant hypertension

Interventions

Control Group:traditional method of drug selection
Research Group:New method of drug selection

Sponsors

Tianjin Beichen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. resistant hypertension; 2. Aged 18 to 75 years old; 3. To be able to and willing to provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Severe liver and kidney disease; 2. The pregnent woman; 3. Patients who have previous cancer treatments; 4. The secondary hypertension; 5. The poor compliance

Design outcomes

Primary

MeasureTime frame
the compliance rate of blood pressure;—

Secondary

MeasureTime frame
Major adverse events;—

Countries

China

Contacts

Public ContactJia Zhi

Tianjin Beichen Hospital

johnbikzly@163.com+86 13920323195

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026